- Corporate Officers - M
- Machado Patrick
Insider Trading History of Machado Patrick
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Machado Patrick since 2007.
This trader's CIK number is 1311210.
At the time of last reporting, Machado Patrick was the Director of Adverum Biotechnologies, Inc.. (stock ticker symbol ADVM).
Also see all insider trading activities at Adverum Biotechnologies, Inc..
Note that in the past
Machado Patrick also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Sio Gene Therapies Inc. (AXON) by Machado Patrick
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2019 | AXON | 6,666,667 | $10,000,000 | 0 | $0 | 0 | $0 |
2018 | AXON | 24,285,714 | $34,999,999 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Adverum Biotechnologies, Inc. (ADVM) by Machado Patrick
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2021 | ADVM | 20,000 | $214,370 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Urovant Sciences Ltd. (UROV) by Machado Patrick
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2019 | UROV | 156,344 | $1,251,526 | 0 | $0 | 0 | $0 |
2018 | UROV | 2,678,571 | $37,499,994 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Myovant Sciences Ltd. (MYOV) by Machado Patrick
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2019 | MYOV | 2,424,242 | $19,999,996 | 0 | $0 | 0 | $0 |
2018 | MYOV | 1,110,015 | $22,500,004 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Chimerix Inc (CMRX) by Machado Patrick
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2015 | CMRX | 10,000 | $70,850 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Medivation, Inc. (MDVN) by Machado Patrick
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2016 | MDVN | 0 | $0 | 75,000 | $2,848,725 | 75,000 | $252,525 |
2015 | MDVN | 0 | $0 | 179,980 | $14,790,798 | 179,980 | $1,372,982 |
2014 | MDVN | 0 | $0 | 201,580 | $15,760,700 | 200,000 | $2,117,000 |
2013 | MDVN | 0 | $0 | 5,425 | $339,908 | 2,765 | $2,142 |
2012 | MDVN | 0 | $0 | 190,000 | $14,517,550 | 125,584 | $1,367,694 |
2011 | MDVN | 0 | $0 | 49,200 | $1,028,513 | 0 | $0 |
2010 | MDVN | 0 | $0 | 40,000 | $1,488,500 | 0 | $0 |
2009 | MDVN | 0 | $0 | 100,000 | $2,528,743 | 0 | $0 |
2008 | MDVN | 0 | $0 | 40,000 | $742,910 | 0 | $0 |
2007 | MDVN | 0 | $0 | 40,000 | $664,960 | 0 | $0 |
Yearly summary of insider trading at Scynexis Inc (SCYX) by Machado Patrick
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2016 | SCYX | 60,000 | $165,400 | 0 | $0 | 0 | $0 |
Insider trading activities at 7 companies by Machado Patrick:
1. Sio Gene Therapies Inc. (AXON)
2. Adverum Biotechnologies, Inc. (ADVM)
3. Urovant Sciences Ltd. (UROV)
4. Myovant Sciences Ltd. (MYOV)
5. Chimerix Inc (CMRX)
6. Medivation, Inc. (MDVN)
7. Scynexis Inc (SCYX)
Table 1. Insider trading of Sio Gene Therapies Inc. (AXON) by Machado Patrick
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2019-03-18 | AXON | Buy | 6,666,667 | 1.50 | 10,000,000 |
2018-12-18 | AXON | Buy | 10,000,000 | 1.00 | 10,000,000 |
2018-06-05 | AXON | Buy | 14,285,714 | 1.75 | 24,999,999 |
Table 2. Insider trading of Adverum Biotechnologies, Inc. (ADVM) by Machado Patrick
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2021-03-24 | ADVM | Buy | 10,000 | 9.92 | 99,200 |
2021-01-15 | ADVM | Buy | 10,000 | 11.52 | 115,170 |
Table 3. Insider trading of Urovant Sciences Ltd. (UROV) by Machado Patrick
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2019-06-17 | UROV | Buy | 6,541 | 8.54 | 55,827 |
2019-06-18 | UROV | Buy | 6,706 | 8.21 | 55,062 |
2019-06-19 | UROV | Buy | 4,957 | 8.17 | 40,493 |
2019-06-13 | UROV | Buy | 7,367 | 7.95 | 58,545 |
2019-06-14 | UROV | Buy | 7,144 | 7.91 | 56,516 |
2019-06-12 | UROV | Buy | 7,500 | 8.30 | 62,242 |
2019-06-07 | UROV | Buy | 6,649 | 7.96 | 52,959 |
2019-06-10 | UROV | Buy | 7,500 | 8.35 | 62,595 |
2019-06-11 | UROV | Buy | 7,189 | 8.58 | 61,695 |
2019-06-04 | UROV | Buy | 7,500 | 7.59 | 56,910 |
2019-06-05 | UROV | Buy | 6,540 | 8.02 | 52,418 |
2019-06-06 | UROV | Buy | 7,082 | 8.00 | 56,620 |
2019-06-03 | UROV | Buy | 5,424 | 7.71 | 41,813 |
2019-05-31 | UROV | Buy | 5,071 | 7.70 | 39,041 |
2019-05-30 | UROV | Buy | 7,251 | 8.44 | 61,198 |
2019-05-24 | UROV | Buy | 3,796 | 7.70 | 29,232 |
2019-05-28 | UROV | Buy | 3,807 | 7.68 | 29,245 |
2019-05-29 | UROV | Buy | 6,882 | 7.55 | 51,986 |
2019-05-21 | UROV | Buy | 9,995 | 8.52 | 85,107 |
2019-05-22 | UROV | Buy | 5,033 | 8.06 | 40,555 |
2019-05-23 | UROV | Buy | 4,802 | 7.76 | 37,253 |
2019-05-17 | UROV | Buy | 6,200 | 7.36 | 45,644 |
2019-05-16 | UROV | Buy | 5,408 | 6.79 | 36,720 |
2019-05-20 | UROV | Buy | 10,000 | 8.19 | 81,850 |
2018-10-01 | UROV | Buy | 2,678,571 | 14.00 | 37,499,994 |
Table 4. Insider trading of Myovant Sciences Ltd. (MYOV) by Machado Patrick
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2019-06-04 | MYOV | Buy | 2,424,242 | 8.25 | 19,999,996 |
2018-04-02 | MYOV | Buy | 1,110,015 | 20.27 | 22,500,004 |
Table 5. Insider trading of Chimerix Inc (CMRX) by Machado Patrick
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2015-12-29 | CMRX | Buy | 10,000 | 7.08 | 70,850 |
Table 6. Insider trading of Medivation, Inc. (MDVN) by Machado Patrick
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2016-01-19 | MDVN | Option Ex | 75,000 | 3.37 | 252,525 |
2016-01-19 | MDVN | Sale | 75,000 | 37.98 | 2,848,725 |
2015-09-25 | MDVN | Sale | 71,980 | 42.26 | 3,042,090 |
2015-09-25 | MDVN | Option Ex | 71,980 | 4.69 | 337,802 |
2015-06-04 | MDVN | Option Ex | 36,000 | 9.38 | 337,860 |
2015-06-04 | MDVN | Sale | 36,000 | 118.14 | 4,253,040 |
2015-02-10 | MDVN | Option Ex | 36,000 | 9.38 | 337,860 |
2015-02-10 | MDVN | Sale | 36,000 | 102.91 | 3,704,868 |
2015-01-27 | MDVN | Sale | 36,000 | 105.30 | 3,790,800 |
2015-01-27 | MDVN | Option Ex | 36,000 | 9.98 | 359,460 |
2014-12-03 | MDVN | Sale | 1,580 | 113.00 | 178,540 |
2014-02-18 | MDVN | Option Ex | 40,000 | 10.59 | 423,400 |
2014-02-18 | MDVN | Sale | 40,000 | 82.37 | 3,294,920 |
2014-02-11 | MDVN | Option Ex | 40,000 | 10.59 | 423,400 |
2014-02-11 | MDVN | Sale | 40,000 | 80.62 | 3,224,920 |
2014-02-05 | MDVN | Option Ex | 40,000 | 10.59 | 423,400 |
2014-02-05 | MDVN | Sale | 40,000 | 73.73 | 2,949,320 |
2014-01-28 | MDVN | Sale | 40,000 | 75.55 | 3,021,880 |
2014-01-28 | MDVN | Option Ex | 40,000 | 10.59 | 423,400 |
2014-01-21 | MDVN | Option Ex | 40,000 | 10.59 | 423,400 |
2014-01-21 | MDVN | Sale | 40,000 | 77.28 | 3,091,120 |
2013-12-03 | MDVN | Sale | 5,425 | 62.66 | 339,908 |
2013-11-07 | MDVN | Option Ex | 2,765 | .78 | 2,142 |
2012-10-03 | MDVN | Sale | 5,100 | 51.08 | 260,482 |
2012-10-02 | MDVN | Sale | 9,400 | 57.08 | 536,505 |
2012-10-03 | MDVN | Option Ex | 5,100 | 6.74 | 34,374 |
2012-10-01 | MDVN | Sale | 5,500 | 57.04 | 313,736 |
2012-10-02 | MDVN | Option Ex | 9,400 | 6.31 | 59,313 |
2012-10-01 | MDVN | Option Ex | 5,500 | 5.88 | 32,340 |
2012-09-07 | MDVN | Option Ex | 20,000 | 11.76 | 235,200 |
2012-09-07 | MDVN | Sale | 20,000 | 105.94 | 2,118,700 |
2012-07-02 | MDVN | Sale | 10,000 | 94.11 | 941,100 |
2012-07-02 | MDVN | Option Ex | 10,000 | 11.76 | 117,600 |
2012-05-24 | MDVN | Sale | 9,400 | 89.17 | 838,216 |
2012-05-24 | MDVN | Option Ex | 9,400 | 11.76 | 110,544 |
2012-05-22 | MDVN | Sale | 600 | 89.16 | 53,496 |
2012-05-22 | MDVN | Option Ex | 600 | 11.76 | 7,056 |
2012-05-14 | MDVN | Option Ex | 10,000 | 11.76 | 117,600 |
2012-05-14 | MDVN | Sale | 10,000 | 84.31 | 843,100 |
2012-04-27 | MDVN | Option Ex | 10,000 | 11.76 | 117,600 |
2012-04-27 | MDVN | Sale | 10,000 | 80.16 | 801,630 |
2012-03-08 | MDVN | Sale | 10,000 | 75.10 | 751,000 |
2012-03-08 | MDVN | Option Ex | 10,000 | 11.76 | 117,600 |
2012-02-07 | MDVN | Option Ex | 16,391 | 11.76 | 192,758 |
2012-02-08 | MDVN | Sale | 57,093 | 69.73 | 3,981,094 |
2012-02-07 | MDVN | Sale | 42,907 | 71.75 | 3,078,491 |
2012-02-08 | MDVN | Option Ex | 19,193 | 11.76 | 225,709 |
2011-06-01 | MDVN | Sale | 28,200 | 24.15 | 681,030 |
2011-02-09 | MDVN | Sale | 2,800 | 15.55 | 43,528 |
2011-02-10 | MDVN | Sale | 14,000 | 17.06 | 238,826 |
2011-02-07 | MDVN | Sale | 4,200 | 15.51 | 65,129 |
2010-02-19 | MDVN | Sale | 30,000 | 37.26 | 1,117,800 |
2010-01-20 | MDVN | Sale | 10,000 | 37.07 | 370,700 |
2009-12-07 | MDVN | Sale | 20,000 | 33.27 | 665,400 |
2009-11-11 | MDVN | Sale | 20,000 | 28.28 | 565,600 |
2009-09-09 | MDVN | Sale | 6,461 | 26.00 | 167,953 |
2009-09-10 | MDVN | Sale | 13,539 | 25.79 | 349,211 |
2009-06-30 | MDVN | Sale | 11,273 | 22.23 | 250,564 |
2009-07-01 | MDVN | Sale | 8,727 | 22.82 | 199,115 |
2009-03-18 | MDVN | Sale | 20,000 | 16.55 | 330,900 |
2008-12-03 | MDVN | Sale | 10,000 | 14.12 | 141,240 |
2008-09-25 | MDVN | Sale | 10,000 | 29.64 | 296,390 |
2008-06-09 | MDVN | Sale | 10,000 | 14.90 | 149,030 |
2008-03-03 | MDVN | Sale | 10,000 | 15.62 | 156,250 |
2007-12-03 | MDVN | Sale | 10,000 | 13.10 | 131,030 |
2007-09-19 | MDVN | Sale | 10,000 | 18.92 | 189,210 |
2007-06-05 | MDVN | Sale | 10,000 | 16.67 | 166,720 |
2007-03-16 | MDVN | Sale | 10,000 | 17.80 | 178,000 |
Table 7. Insider trading of Scynexis Inc (SCYX) by Machado Patrick
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2016-09-15 | SCYX | Buy | 40,000 | 2.94 | 117,600 |
2016-06-24 | SCYX | Buy | 20,000 | 2.39 | 47,800 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Machado Patrick
(Director of Adverum Biotechnologies, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.